Company Overview of Phyton Biotech, Inc.
Phyton Biotech, Inc. produces human therapeutic agents through plant cell fermentation. It manufactures transgenic proteins and small molecules. The company produces paclitaxel, an active ingredient in oncology products for the treatment of breast, ovarian, and other forms of cancer. The company was founded in 1990 and is based in East Windsor, New Jersey. Its research and development center is located in Delta, Canada; and plant cell culture manufacturing facility is located in Ahrensburg, Germany. As of November 26, 2003, Phyton Biotech, Inc. operates as a subsidiary of DFB Pharmaceuticals, Inc.
1527 Cliveden Avenue
Delta, BC V3M 6P7
Founded in 1990
Key Executives for Phyton Biotech, Inc.
Similar Private Companies By Industry
|Jellett Biotek Limited||Americas|
|2007262 Ontario, Inc.||Americas|
|BioAxone Therapeutic, Inc.||Americas|
|Alpha Cancer Technologies Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Phyton Biotech, Inc., please visit www.phytonbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.